GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
- Conditions
- Neoplasms, Breast
- Interventions
- Biological: Immunotherapeutic SB719125 (Primary)
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 61
- Registration Number
- NCT00058526
- Locations
- 🇮🇹
GSK Investigational Site, Perugia, Umbria, Italy
HerpeVac Trial for Young Women
- Conditions
- Herpes Simplex Infection
- Interventions
- Biological: HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccineBiological: Havrix™, GlaxoSmithKline (GSK) Biologicals' licensed Hepatitis A vaccine
- First Posted Date
- 2003-04-01
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 8323
- Registration Number
- NCT00057330
- Locations
- 🇨🇦
GSK Investigational Site, Sherbrooke, Quebec, Canada
An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2003-03-28
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 365
- Registration Number
- NCT00057226
- Locations
- 🇺🇸
GSK Investigational Site, Bellevue, Washington, United States
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2003-03-28
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 367
- Registration Number
- NCT00057213
- Locations
- 🇺🇸
GSK Investigational Site, Salt Lake City, Utah, United States
An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2003-03-28
- Last Posted Date
- 2010-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 546
- Registration Number
- NCT00057239
- Locations
- 🇺🇸
GSK Investigational Site, Brown Deer, Wisconsin, United States
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
- First Posted Date
- 2003-03-13
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 8231
- Registration Number
- NCT00056407
- Locations
GSK Investigational Site
Bipolar Disorder Study for Men and Women
- First Posted Date
- 2003-03-11
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 150
- Registration Number
- NCT00056277
- Locations
- 🇺🇸
GSK Investigational Site, Brown Deer, Wisconsin, United States
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
- Conditions
- HIV Infection
- First Posted Date
- 2003-02-05
- Last Posted Date
- 2010-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 345
- Registration Number
- NCT00053638
- Locations
- 🇺🇸
GSK Investigational Site, Green Bay, Wisconsin, United States
Effects Of Antidepressants On Sexual Functioning In Adults
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2003-01-08
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 425
- Registration Number
- NCT00051272
- Locations
- 🇺🇸
GSK Investigational Site, Yakima, Washington, United States
Effects of Antidepressants on Sexual Functioning
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2003-01-08
- Last Posted Date
- 2010-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 420
- Registration Number
- NCT00051259
- Locations
- 🇺🇸
GSK Investigational Site, Madison, Wisconsin, United States